Cosmax
Cosmax BTI, Inc. engages in the research, development, production, and sale of cosmetics, health functional foods, pharmaceuticals, and special containers in South Korea. The company offers cosmetics products, including skincare, mask, cleansing, hair, bath and body, sun care, makeup, cushion, eye and lip makeup, nail, and fragrance products; baby and child cosmetic products; Korean herbal cosmet… Read more
Cosmax (044820) - Total Liabilities
Latest total liabilities as of September 2025: ₩711.31 Billion KRW
Based on the latest financial reports, Cosmax (044820) has total liabilities worth ₩711.31 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cosmax - Total Liabilities Trend (2003–2024)
This chart illustrates how Cosmax's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cosmax Competitors by Total Liabilities
The table below lists competitors of Cosmax ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Birchtech Corp.
OTCQB:BCHT
|
USA | $11.28 Million |
|
MS Industrie AG
F:MSAG
|
Germany | €76.85 Million |
|
Dual Co Ltd
KO:016740
|
Korea | ₩269.69 Billion |
|
SMO
BK:SMO
|
Thailand | ฿2.54 Billion |
|
Hancock & Gore Ltd
AU:HNG
|
Australia | AU$28.02 Million |
|
Groundhog Inc.
TW:6906
|
Taiwan | NT$152.25 Million |
|
Nykode Therapeutics AS
PINK:VACBF
|
USA | $8.42 Million |
|
Chenghe Acquisition II Co.
NYSE MKT:CHEB
|
USA | $6.90 Million |
Liability Composition Analysis (2003–2024)
This chart breaks down Cosmax's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.89 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.73 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cosmax's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cosmax (2003–2024)
The table below shows the annual total liabilities of Cosmax from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩672.67 Billion | +7.48% |
| 2023-12-31 | ₩625.88 Billion | +2.54% |
| 2022-12-31 | ₩610.37 Billion | -0.39% |
| 2021-12-31 | ₩612.77 Billion | +11.55% |
| 2020-12-31 | ₩549.33 Billion | +2.35% |
| 2019-12-31 | ₩536.73 Billion | +3.22% |
| 2018-12-31 | ₩519.97 Billion | +30.93% |
| 2017-12-31 | ₩397.14 Billion | +22.55% |
| 2016-12-31 | ₩324.06 Billion | +47.87% |
| 2015-12-31 | ₩219.15 Billion | +68.57% |
| 2014-12-31 | ₩130.01 Billion | -36.78% |
| 2013-12-31 | ₩205.63 Billion | +27.18% |
| 2012-12-31 | ₩161.69 Billion | +17.00% |
| 2011-12-31 | ₩138.20 Billion | +60.96% |
| 2010-12-31 | ₩85.86 Billion | +3.59% |
| 2009-12-31 | ₩82.88 Billion | +7.72% |
| 2008-12-31 | ₩76.95 Billion | +25.29% |
| 2007-12-31 | ₩61.42 Billion | +166.72% |
| 2004-12-31 | ₩23.03 Billion | -1.94% |
| 2003-12-31 | ₩23.48 Billion | -- |